The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man.
1. Opioid drugs act on specific receptors which are principally classified into mu, delta and kappa subtypes. Spiradoline (U-62066E) is a kappa-selective agent which has been shown to possess potent anti-nociceptive effects but does not show cross tolerance with morphine. 2. We have assessed the neu...
Main Authors: | Ur, E, Wright, D, Bouloux, P, Grossman, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
1997
|
Títulos similares
-
Effect of adrenergic antagonism on the growth hormone, prolactin and cortisol response to a synthetic opioid agonist in man.
por: Bouloux, P, et al.
Publicado: (1986) -
Therapeutic Potential of Kappa Opioid Agonists
por: Tyler C. Beck, et al.
Publicado: (2019-06-01) -
Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism
por: Madigan L. Bedard, et al.
Publicado: (2024-06-01) -
Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation
por: Kook Jin Chun, et al.
Publicado: (2010-02-01) -
Novel Kappa-Opioid Receptor Agonist for the Treatment of Cholestatic Pruritus: Systematic Review
por: Adrian Joseph Michel Bailey, et al.
Publicado: (2022-05-01)